COVID-19 clinical trials: Ethical and scientific consequences of the RECOVERY trial results.

Dal-Ré, Rafael; Porcher, Raphaël; Gluud, Christian

Dal-Ré, Rafael; Porcher, Raphaël; Gluud, Christian.

Dal-Ré R; Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
Porcher R; Centre of Research in Epidemiology and Statistics, Université de Paris, Joint Research Unit 1153, Institute National de la Santé et de la Recherche Médicale, Paris, France.
Gluud C; The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Basic Clin Pharmacol Toxicol ; 127(6): 445-447, 2020 Dec.

Article in English | MEDLINE | ID: covidwho-760110

Subject(s)

COVID-19 Drug Treatment; COVID-19/epidemiology; Randomized Controlled Trials as Topic/methods; Clinical Protocols/standards; Humans; Pandemics; Randomized Controlled Trials as Topic/standards; Research Design; SARS-CoV-2

Keywords

COVID-19; RECOVERY; ethics; randomized controlled trials; results

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / COVID-19 / COVID-19 Drug Treatment Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Basic Clin Pharmacol Toxicol Journal subject: Pharmacology / Toxicology Year: 2020 Document Type: Article Affiliation country: Bcpt.13489

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google